Filana Therapeutics (FLNA) Interest Expenses (2010 - 2026)
Filana Therapeutics (FLNA) posted quarterly Interest Expenses of $164000.0 for Q2 2026, up 5.13% year-over-year from $156000.0 in Q2 2025, and down 20.39% quarter-over-quarter from $206000.0 in Q1 2026.
Filana Therapeutics (FLNA) Interest Expenses (2010 - 2026) Analysis & Trends
Filana Therapeutics' Interest Expenses history runs 17 years deep, the most recent figure standing at $164000.0 for Q2 2026.
- In Q2 2026, Interest Expenses rose 5.13% year-over-year to $164000.0; the TTM figure through Jun 2026 stood at $732000.0 (down 2.14% YoY), while the FY2025 annual figure was $111.9 million, up 15.73% from the prior year.
- Interest Expenses for Q2 2026 stood at $164000.0, down from $206000.0 in the prior quarter.
- The five-year high for Interest Expenses was $430000.0 in Q4 2022, with the low at $132000.0 in Q4 2025.
- The 5-year median for Interest Expenses is $236500.0 (2024), against an average of $265277.8.
- The sharpest annual moves came in 2022 and 2024: Interest Expenses surged 948.78% in 2022, then plunged 49.15% in 2024.
- Filana Therapeutics' Interest Expenses stood at $430000.0 in 2022, then plunged by 31.86% to $293000.0 in 2023, then slumped by 49.15% to $149000.0 in 2024, then slipped by 11.41% to $132000.0 in 2025, then climbed by 24.24% to $164000.0 in 2026.
- Business Quant data shows FLNA's Interest Expenses at $164000.0 in Q2 2026, $206000.0 in Q1 2026, and $132000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 82.05 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 20.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 93.62 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -4.89 Mn |
| 10 | Filana Therapeutics | 45.29 Mn | 45.29 Mn | - | 164,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 164,000.00 |
| Jun 30, 2026 | 164,000.00 |
| Mar 31, 2026 | 206,000.00 |
| Mar 31, 2026 | 206,000.00 |
| Dec 31, 2025 | 132,000.00 |
| Dec 31, 2025 | 132,000.00 |
| Sep 30, 2025 | 230,000.00 |
| Sep 30, 2025 | 230,000.00 |
| Jun 30, 2025 | 156,000.00 |
| Jun 30, 2025 | 156,000.00 |
| Mar 31, 2025 | 217,000.00 |
| Mar 31, 2025 | 217,000.00 |
| Dec 31, 2024 | 149,000.00 |
| Dec 31, 2024 | 149,000.00 |
| Sep 30, 2024 | 226,000.00 |
| Sep 30, 2024 | 226,000.00 |
| Jun 30, 2024 | 215,000.00 |
| Jun 30, 2024 | 215,000.00 |
| Mar 31, 2024 | 243,000.00 |
| Mar 31, 2024 | 243,000.00 |